Minghui Pharmaceutical (hangzhou) Ltd

This study is testing a new drug called MHB009C in 200 people with advanced solid tumors that have not responded to standard treatments. The goal is to find a safe dose and see if the drug can shrink tumors. Participants will receive the drug by IV and be closely monitored for si…

This study tests a new drug called MHB018A for people with chronic moderate-to-severe thyroid eye disease, a condition that causes eye bulging and discomfort. About 150 adults aged 18-75 will receive either the drug or a placebo every 4 weeks for 6 months. The main goal is to see…

This study tests a new drug called MHB036C, given with other anti-cancer treatments, for people with advanced lung cancer that has not responded to standard therapies. The goal is to find the safest dose and see if it shrinks tumors. About 300 adults aged 18-75 with good performa…

This study tests a new medicine called MHB018A for people with active moderate-to-severe thyroid eye disease, which causes bulging eyes and discomfort. About 108 adults aged 18-75 will receive either the drug or a placebo every 4 weeks for 6 months. The main goal is to see if the…

This study tests an injection called MHB018A for people with moderate-to-severe thyroid eye disease, which causes bulging eyes and discomfort. About 258 adults who completed earlier studies will receive the drug for 24 weeks to see if it reduces eye bulging and prevents symptoms …

This study tests two experimental drugs, MHB036C and MHB039A, given together to people with advanced breast cancer or other advanced solid tumors that have spread. The goal is to see if the combination can shrink tumors and how safe it is. About 210 adults aged 18 to 75 with meas…

This study tests two experimental drugs, MHB088C and MHB039A, given together to adults with advanced solid tumors that have not responded to standard treatments. The goal is to find a safe dose and see if the combination can shrink tumors. About 116 participants will take part in…

This study tests a new drug called MHB042C in about 200 adults with advanced solid tumors that have not responded to standard treatments. The goal is to find a safe dose and see if the drug can shrink tumors. Participants will receive the drug by IV and be closely monitored for s…

This study tests a new drug called MHB046C in 200 adults with advanced solid tumors that have not responded to standard treatments. The goal is to find a safe dose and see if the drug can shrink tumors. Participants receive the drug by IV and are closely monitored for side effect…

This study tests a new drug called MHB048C in people with advanced solid tumors that have not responded to standard treatments. The goal is to find a safe dose and see if it can shrink tumors. About 200 adults will take part in this early-phase trial.